Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.

Miller RA, Chu Q, Le Lay J, Scherer PE, Ahima RS, Kaestner KH, Foretz M, Viollet B, Birnbaum MJ.

J Clin Invest. 2011 Jun;121(6):2518-28. doi: 10.1172/JCI45942. Epub 2011 May 23.

2.

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F, Viollet B.

J Clin Invest. 2010 Jul;120(7):2355-69. doi: 10.1172/JCI40671. Epub 2010 Jun 23.

3.

Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.

Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P.

World J Gastroenterol. 2015 Jul 7;21(25):7777-85. doi: 10.3748/wjg.v21.i25.7777.

4.

The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.

Patel K, Foretz M, Marion A, Campbell DG, Gourlay R, Boudaba N, Tournier E, Titchenell P, Peggie M, Deak M, Wan M, Kaestner KH, Göransson O, Viollet B, Gray NS, Birnbaum MJ, Sutherland C, Sakamoto K.

Nat Commun. 2014 Aug 4;5:4535. doi: 10.1038/ncomms5535.

5.

Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis.

Yoon YS, Ryu D, Lee MW, Hong S, Koo SH.

Exp Mol Med. 2009 Aug 31;41(8):577-83. doi: 10.3858/emm.2009.41.8.063.

6.

AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.

Lee JM, Seo WY, Song KH, Chanda D, Kim YD, Kim DK, Lee MW, Ryu D, Kim YH, Noh JR, Lee CH, Chiang JY, Koo SH, Choi HS.

J Biol Chem. 2010 Oct 15;285(42):32182-91. doi: 10.1074/jbc.M110.134890. Epub 2010 Aug 5.

7.

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC.

Science. 2005 Dec 9;310(5754):1642-6. Epub 2005 Nov 24.

8.

AMP-activated protein kinase in metabolic control and insulin signaling.

Towler MC, Hardie DG.

Circ Res. 2007 Feb 16;100(3):328-41. Review.

9.

Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes.

Xiong J, Yang H, Wu L, Shang W, Shan E, Liu W, Hu G, Xi T, Yang J.

Int J Biochem Cell Biol. 2014 Sep;54:236-44. doi: 10.1016/j.biocel.2014.07.019. Epub 2014 Aug 5.

PMID:
25102273
10.

Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.

Bang S, Chen Y, Ahima RS, Kim SF.

Mol Endocrinol. 2014 Jul;28(7):1186-93. doi: 10.1210/me.2014-1134. Epub 2014 May 30.

11.

Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.

Itoh Y, Sanosaka M, Fuchino H, Yahara Y, Kumagai A, Takemoto D, Kagawa M, Doi J, Ohta M, Tsumaki N, Kawahara N, Takemori H.

J Biol Chem. 2015 Jul 17;290(29):17879-93. doi: 10.1074/jbc.M115.640821. Epub 2015 Jun 5.

12.
13.

Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.

Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ.

Diabetes. 2006 Jun;55(6):1840-6.

14.

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway.

Awazawa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, Kadowaki T.

Biochem Biophys Res Commun. 2009 Apr 24;382(1):51-6. doi: 10.1016/j.bbrc.2009.02.131. Epub 2009 Feb 28.

PMID:
19254698
15.

Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression.

Viana AY, Sakoda H, Anai M, Fujishiro M, Ono H, Kushiyama A, Fukushima Y, Sato Y, Oshida Y, Uchijima Y, Kurihara H, Asano T.

Diabetes Res Clin Pract. 2006 Aug;73(2):135-42. Epub 2006 Feb 28.

PMID:
16503364
16.

Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.

Kim JY, Jo KJ, Kim OS, Kim BJ, Kang DW, Lee KH, Baik HW, Han MS, Lee SK.

Life Sci. 2010 Sep 11;87(11-12):358-66. doi: 10.1016/j.lfs.2010.07.009. Epub 2010 Jul 23.

PMID:
20655933
17.

Effect of LKB1 deficiency on mitochondrial content, fibre type and muscle performance in the mouse diaphragm.

Brown JD, Hancock CR, Mongillo AD, Benjamin Barton J, DiGiovanni RA, Parcell AC, Winder WW, Thomson DM.

Acta Physiol (Oxf). 2011 Apr;201(4):457-66. doi: 10.1111/j.1748-1716.2010.02226.x. Epub 2011 Jan 19.

18.

Role of AMP-activated protein kinase in mechanism of metformin action.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE.

J Clin Invest. 2001 Oct;108(8):1167-74.

19.

Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.

Jeong KJ, Kim do Y, Quan HY, Jo HK, Kim GW, Chung SH.

Fitoterapia. 2014 Mar;93:150-62. doi: 10.1016/j.fitote.2013.12.023. Epub 2014 Jan 11.

PMID:
24418657
20.

Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue.

Niemann B, Pan R, Teschner M, Boening A, Silber RE, Rohrbach S.

Exp Gerontol. 2013 Jan;48(1):55-63. doi: 10.1016/j.exger.2012.04.005. Epub 2012 Apr 23.

PMID:
22546364
Items per page

Supplemental Content

Write to the Help Desk